![Phase I/II trial and pharmacokinetics of intrathecal diaziquone in refractory meningeal malignancies.]()
Phase I/II trial and pharmacokinetics of intrathecal diaziquone in refractory meningeal malignancies.Berg, S L; Balis, F M; Zimm, S; Murphy, R F; Holcenberg, J; Sato, J; Reaman, G; Steinherz, P; Gillespie, A; Doherty, K · Journal of Clinical Oncology · 1992